Drug Regulators
-
{
- All
- News
- Videos
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
- Friday May 1, 2026
- Health | Written by Sambhav Kumar
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
www.ndtv.com
-
Combining These Two Commonly Prescribed Drugs May Reverse Fatty Liver, Reveals Study
- Thursday April 23, 2026
- Health | Written by Varsha Vats
Pemafibrate and Telmisartan are medications primarily used to manage cholesterol and blood pressure, respectively. The study suggests that they may also be highly effective when used together to treat fatty liver disease.
-
www.ndtv.com
-
Public Health Alert: Rajasthan Bans 7 Sub-Standard Medicines
- Thursday April 23, 2026
- Health | Indo Asian Service News
Jaipur, April 22 (IANS) Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality” following laboratory test
-
www.ndtv.com
-
Fake Weight Loss Injections Are Flooding The Market; Doctors Warn Patients Of Serious Health Risks
- Wednesday April 15, 2026
- Health | Written by Rupashi Chhabra
Fake weight loss injections are flooding the market, posing serious health risks. Dr Ravi Malik and Dr Shilpa Bhatte explain in depth about the prevalence of fake weight loss injections and how to safeguard yourself.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
New Study Explains Why Ozempic Doesn't Work For Everyone
- Monday April 13, 2026
- Health | Written by Rupashi Chhabra
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
- Friday April 3, 2026
- Lifestyle | Reuters
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
www.ndtv.com/lifestyle
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
- Friday May 1, 2026
- Health | Written by Sambhav Kumar
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
www.ndtv.com
-
Combining These Two Commonly Prescribed Drugs May Reverse Fatty Liver, Reveals Study
- Thursday April 23, 2026
- Health | Written by Varsha Vats
Pemafibrate and Telmisartan are medications primarily used to manage cholesterol and blood pressure, respectively. The study suggests that they may also be highly effective when used together to treat fatty liver disease.
-
www.ndtv.com
-
Public Health Alert: Rajasthan Bans 7 Sub-Standard Medicines
- Thursday April 23, 2026
- Health | Indo Asian Service News
Jaipur, April 22 (IANS) Prioritising public health and patient safety, the Commissionerate of Food Safety and Drug Control, Rajasthan, has issued an alert regarding seven medicines and declared them “Not of Standard Quality” following laboratory test
-
www.ndtv.com
-
Fake Weight Loss Injections Are Flooding The Market; Doctors Warn Patients Of Serious Health Risks
- Wednesday April 15, 2026
- Health | Written by Rupashi Chhabra
Fake weight loss injections are flooding the market, posing serious health risks. Dr Ravi Malik and Dr Shilpa Bhatte explain in depth about the prevalence of fake weight loss injections and how to safeguard yourself.
-
www.ndtv.com
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
- Tuesday April 21, 2026
- Health | Written by Tanushka Dutta
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
www.ndtv.com
-
New Study Explains Why Ozempic Doesn't Work For Everyone
- Monday April 13, 2026
- Health | Written by Rupashi Chhabra
A new study published in Genome Medicine details that Ozempic doesn't work for everyone in the same manner. Here is what you need to know about its mechanisms and why making science-based medical decisions is important.
-
www.ndtv.com
-
"Weight-Loss Injections Are Not For Wedding Prep Shortcut", Doctors Warn Against Misuse Of Ozempic, Mounjaro
- Monday April 6, 2026
- Health | Written by Debosmita Ghosh
These medications are designed for people with obesity or related health conditions, not for short-term aesthetic goals. When used by otherwise healthy individuals aiming for quick slimming, the balance between benefit and risk often becomes unfavour
-
www.ndtv.com
-
With Rs 13,000-25,000 Per Dose, Weight-Loss Drugs Are Changing Indian Weddings For Brides
- Friday April 3, 2026
- Lifestyle | Reuters
The lowest Mounjaro injection pen dose sells for Rs 13,125 per month, while the highest dose costs Rs 25,781. Novo is selling the lowest Wegovy dose for Rs 5,660 and the highest for Rs 16,400 a month
-
www.ndtv.com/lifestyle
-
FDA Approves New Weight-Loss Pill For Use At Any Time Of Day
- Thursday April 2, 2026
- Science | Edited by Nikhil Pandey
The US regulator has approved Eli Lilly's new oral weight-loss drug Foundayo through a fast-track process, offering a more convenient and potentially affordable alternative to injectable obesity treatments.
-
www.ndtv.com
-
GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts
- Monday March 30, 2026
- Health | Asian News International
Experts warn that GLP1 drugs like Ozempic and Wegovy aren't quick fixes. There are misuse risks that are involved as shortages, side effects, and weight regain are possible without medical supervision.
-
www.ndtv.com